Hebei Changshan Biochemical Pharmaceutical Co Ltd Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Hebei Changshan Biochemical Pharmaceutical Co Ltd - Alpha Spread

Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255

Watchlist Manager
Hebei Changshan Biochemical Pharmaceutical Co Ltd Logo
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
Watchlist
Price: 10.04 CNY -1.38% Market Closed
Market Cap: 9.1B CNY
Have any thoughts about
Hebei Changshan Biochemical Pharmaceutical Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Hebei Changshan Biochemical Pharmaceutical Co Ltd

Wall Street analysts forecast Hebei Changshan Biochemical Pharmaceutical Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hebei Changshan Biochemical Pharmaceutical Co Ltd is 9 CNY .

Lowest
Price Target
Not Available
Average
Price Target
9 CNY
10% Downside
Highest
Price Target
Not Available
Hebei Changshan Biochemical Pharmaceutical Co Ltd Competitors:
Price Targets
MMQ
Mind Medicine (MindMed) Inc
308% Upside
IPCALAB
IPCA Laboratories Ltd
8% Downside
AMPH
Amphastar Pharmaceuticals Inc
34% Upside
600216
Zhejiang Medicine Co Ltd
26% Upside
688356
Jenkem Technology Co Ltd
132% Upside
ITCI
Intra-Cellular Therapies Inc
31% Upside
1177
Sino Biopharmaceutical Ltd
48% Upside
PFIZER
Pfizer Ltd
9% Downside

Revenue
Forecast

Revenue Estimate
Hebei Changshan Biochemical Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Hebei Changshan Biochemical Pharmaceutical Co Ltd's revenue is 6%. The projected CAGR for the next 6 years is -3%.

6%
Past Growth
-3%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Hebei Changshan Biochemical Pharmaceutical Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Hebei Changshan Biochemical Pharmaceutical Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Hebei Changshan Biochemical Pharmaceutical Co Ltd's stock price target?
Price Target
9 CNY

According to Wall Street analysts, the average 1-year price target for Hebei Changshan Biochemical Pharmaceutical Co Ltd is 9 CNY .

What is Hebei Changshan Biochemical Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
-3%

For the last 8 years the compound annual growth rate for Hebei Changshan Biochemical Pharmaceutical Co Ltd's revenue is 6%. The projected CAGR for the next 6 years is -3%.

Back to Top